Company: XOMAP
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001558370-25-007494
Chunk: 4

Company: XOMA Royalty Corp
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 1C
Chunk 4
---
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

XOMA ROYALTY CORPORATION 

CONDENSED CONSOLIDATED BALANCE SHEETS 

(in thousands, except share and per share amounts)

​​​​​​​​​March 31, ​December 31, ​​2025​2024⁽¹⁾ASSETS​​(unaudited)​​​Current assets:​​​​​​Cash and cash equivalents ​$ 90,265​$ 101,654Short-term restricted cash​​ 1,410​​ 1,330Investment in equity securities​​ 2,382​​ 3,529Trade and other receivables, net​  5,544​  1,839Short-term royalty and commercial payment receivables under the EIR method​​ 12,240​​ 14,763Short-term royalty and commercial payment receivables under the cost recovery method​​ 413​​ 413Prepaid expenses and other current assets​  971​  2,076Total current assets​  113,225​  125,604​​​​​​​Long-term restricted cash​​ 3,352​  3,432Property and equipment, net​  29​  32Operating lease right-of-use assets​​ 304​​ 319Long-term royalty and commercial payment receivables under the EIR method​  4,857​  4,970Long-term royalty and commercial payment receivables under the cost recovery method​​ 59,916​​ 55,936Exarafenib milestone asset (Note 4)​  3,307​  3,214Investment in warrants​​ 605​​ —Intangible assets, net​​ 25,365​​ 25,909Other assets - long term​  1,790​  1,861Total assets​$ 212,750​$ 221,277​​​​​​​LIABILITIES AND STOCKHOLDERS’ EQUITY​​​​​​Current liabilities:​​​​​​Accounts payable​$ 2,319​$ 1,053Accrued and other liabilities ​  1,221​  5,752Contingent consideration under RPAs, AAAs, and CPPAs ​​ —​​ 3,000Operating lease liabilities​​ 459​​ 446Unearned revenue recognized under units-of-revenue method​  1,370​  1,361